Limits...
Conjunctivolimbal autograft using a fibrin adhesive in pterygium surgery.

Kim HH, Mun HJ, Park YJ, Lee KW, Shin JP - Korean J Ophthalmol (2008)

Bottom Line: Graft dehiscence was seen in two eyes (5.6%), one eye was treated with remedial sutures, and the other eye showed a spontaneous healing without remedial sutures.Transient graft edema occurred in four eyes (11.2%) but subsided spontaneously within a month.Therefore, the fibrin bioadhesive is a safe and effective tool to attach conjunctivolimbal autograft in primary pterygium surgery.

View Article: PubMed Central - PubMed

Affiliation: Department of Ophthalmology, Cheil Eye Hospital, Daegu, Korea.

ABSTRACT

Purpose: To evaluate the efficacy and safety of fibrin bioadhesive in conjunctivolimbal autograft surgery for primary pterygium.

Methods: Thirty-six eyes in 34 patients were reviewed with nasal primary pterygium who were treated with pterygium excision with superior conjunctivolimbal transplantation with fibrin bioadhesive. Surgical durations were recorded and the patients were followed up on the first day after surgery and then at 1, 2, 4, 8 and 12 weeks postoperatively. The graft-recipient site attachments were examined and subjective symptoms of patients were recorded at every follow-up examinations.

Results: The mean patient age was 57.9+/-10.1 (ranging from 33 to 83) years. The mean follow-up period was 22.05+/-5.78 weeks. The mean surgery time was 18.04+/-5.65 minutes. The subjective symptoms (pain, foreign body sensation, tearing and discomfort) disappeared in 23 of 36 eyes (64%) in one week after surgery, and all discomforts subsided within two weeks after surgery in all patients. The conjunctivolimbal autograft was correctly positioned and fixed in 34 of 36 eyes (94.4%) throughout the follow-up period. Graft dehiscence was seen in two eyes (5.6%), one eye was treated with remedial sutures, and the other eye showed a spontaneous healing without remedial sutures. Transient graft edema occurred in four eyes (11.2%) but subsided spontaneously within a month. There were no cases of pterygium regrowth or complications due to the fibrin bioadhesive.

Conclusions: The use of fibrin bioadhesive in conjunctivolimbal autograft surgery in primary pterygium simplifies surgical techniques, shorten surgical duration, and produce less postoperative subjective symptoms . Therefore, the fibrin bioadhesive is a safe and effective tool to attach conjunctivolimbal autograft in primary pterygium surgery.

Show MeSH

Related in: MedlinePlus

(A) Mild shrinkage (between arrows) of the conjunctivolimbal autograft and recipient conjunctiva was noted 2 weeks after surgery: Secondary epithelialization and spontaneous closure of the wound gap occurred in one week. (B) Transient edema (arrows) of conjunctivolimbal autograft 2 weeks after surgery: Spontaneous resolution occurred in one month.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2629906&req=5

Figure 4: (A) Mild shrinkage (between arrows) of the conjunctivolimbal autograft and recipient conjunctiva was noted 2 weeks after surgery: Secondary epithelialization and spontaneous closure of the wound gap occurred in one week. (B) Transient edema (arrows) of conjunctivolimbal autograft 2 weeks after surgery: Spontaneous resolution occurred in one month.

Mentions: In 34 of 36 (94.4%) cases, the conjunctivolimbal autograft was observed to be correctly positioned and fixed in all the follow-up exams (Fig. 2, 3). Graft dehiscence was observed in two eyes (5.6%), one eye was given remedial sutures, and the other eye showed spontaneous healing without remedial sutures after a week. Transient graft edema occurred in four eyes (11.2%) but spontaneously subsided within a month (Fig. 4). There were no cases of pterygium regrowth or complications due to the fibrin bioadhesive during the follow-up period.


Conjunctivolimbal autograft using a fibrin adhesive in pterygium surgery.

Kim HH, Mun HJ, Park YJ, Lee KW, Shin JP - Korean J Ophthalmol (2008)

(A) Mild shrinkage (between arrows) of the conjunctivolimbal autograft and recipient conjunctiva was noted 2 weeks after surgery: Secondary epithelialization and spontaneous closure of the wound gap occurred in one week. (B) Transient edema (arrows) of conjunctivolimbal autograft 2 weeks after surgery: Spontaneous resolution occurred in one month.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2629906&req=5

Figure 4: (A) Mild shrinkage (between arrows) of the conjunctivolimbal autograft and recipient conjunctiva was noted 2 weeks after surgery: Secondary epithelialization and spontaneous closure of the wound gap occurred in one week. (B) Transient edema (arrows) of conjunctivolimbal autograft 2 weeks after surgery: Spontaneous resolution occurred in one month.
Mentions: In 34 of 36 (94.4%) cases, the conjunctivolimbal autograft was observed to be correctly positioned and fixed in all the follow-up exams (Fig. 2, 3). Graft dehiscence was observed in two eyes (5.6%), one eye was given remedial sutures, and the other eye showed spontaneous healing without remedial sutures after a week. Transient graft edema occurred in four eyes (11.2%) but spontaneously subsided within a month (Fig. 4). There were no cases of pterygium regrowth or complications due to the fibrin bioadhesive during the follow-up period.

Bottom Line: Graft dehiscence was seen in two eyes (5.6%), one eye was treated with remedial sutures, and the other eye showed a spontaneous healing without remedial sutures.Transient graft edema occurred in four eyes (11.2%) but subsided spontaneously within a month.Therefore, the fibrin bioadhesive is a safe and effective tool to attach conjunctivolimbal autograft in primary pterygium surgery.

View Article: PubMed Central - PubMed

Affiliation: Department of Ophthalmology, Cheil Eye Hospital, Daegu, Korea.

ABSTRACT

Purpose: To evaluate the efficacy and safety of fibrin bioadhesive in conjunctivolimbal autograft surgery for primary pterygium.

Methods: Thirty-six eyes in 34 patients were reviewed with nasal primary pterygium who were treated with pterygium excision with superior conjunctivolimbal transplantation with fibrin bioadhesive. Surgical durations were recorded and the patients were followed up on the first day after surgery and then at 1, 2, 4, 8 and 12 weeks postoperatively. The graft-recipient site attachments were examined and subjective symptoms of patients were recorded at every follow-up examinations.

Results: The mean patient age was 57.9+/-10.1 (ranging from 33 to 83) years. The mean follow-up period was 22.05+/-5.78 weeks. The mean surgery time was 18.04+/-5.65 minutes. The subjective symptoms (pain, foreign body sensation, tearing and discomfort) disappeared in 23 of 36 eyes (64%) in one week after surgery, and all discomforts subsided within two weeks after surgery in all patients. The conjunctivolimbal autograft was correctly positioned and fixed in 34 of 36 eyes (94.4%) throughout the follow-up period. Graft dehiscence was seen in two eyes (5.6%), one eye was treated with remedial sutures, and the other eye showed a spontaneous healing without remedial sutures. Transient graft edema occurred in four eyes (11.2%) but subsided spontaneously within a month. There were no cases of pterygium regrowth or complications due to the fibrin bioadhesive.

Conclusions: The use of fibrin bioadhesive in conjunctivolimbal autograft surgery in primary pterygium simplifies surgical techniques, shorten surgical duration, and produce less postoperative subjective symptoms . Therefore, the fibrin bioadhesive is a safe and effective tool to attach conjunctivolimbal autograft in primary pterygium surgery.

Show MeSH
Related in: MedlinePlus